195 related articles for article (PubMed ID: 26200935)
1. Resveratrol as a novel treatment for diseases with mTOR pathway hyperactivation.
Alayev A; Berger SM; Holz MK
Ann N Y Acad Sci; 2015 Aug; 1348(1):116-23. PubMed ID: 26200935
[TBL] [Abstract][Full Text] [Related]
2. Resveratrol prevents rapamycin-induced upregulation of autophagy and selectively induces apoptosis in TSC2-deficient cells.
Alayev A; Sun Y; Snyder RB; Berger SM; Yu JJ; Holz MK
Cell Cycle; 2014; 13(3):371-82. PubMed ID: 24304514
[TBL] [Abstract][Full Text] [Related]
3. Effects of combining rapamycin and resveratrol on apoptosis and growth of TSC2-deficient xenograft tumors.
Alayev A; Salamon RS; Sun Y; Schwartz NS; Li C; Yu JJ; Holz MK
Am J Respir Cell Mol Biol; 2015 Nov; 53(5):637-46. PubMed ID: 25844891
[TBL] [Abstract][Full Text] [Related]
4. Targeting mTOR: evaluating the therapeutic potential of resveratrol for cancer treatment.
Wu Y; Liu F
Anticancer Agents Med Chem; 2013 Sep; 13(7):1032-8. PubMed ID: 23272906
[TBL] [Abstract][Full Text] [Related]
5. The combination of rapamycin and resveratrol blocks autophagy and induces apoptosis in breast cancer cells.
Alayev A; Berger SM; Kramer MY; Schwartz NS; Holz MK
J Cell Biochem; 2015 Mar; 116(3):450-7. PubMed ID: 25336146
[TBL] [Abstract][Full Text] [Related]
6. Anti-Breast Cancer Potential of Quercetin via the Akt/AMPK/Mammalian Target of Rapamycin (mTOR) Signaling Cascade.
Rivera Rivera A; Castillo-Pichardo L; Gerena Y; Dharmawardhane S
PLoS One; 2016; 11(6):e0157251. PubMed ID: 27285995
[TBL] [Abstract][Full Text] [Related]
7. Resveratrol directly targets DDX5 resulting in suppression of the mTORC1 pathway in prostate cancer.
Taniguchi T; Iizumi Y; Watanabe M; Masuda M; Morita M; Aono Y; Toriyama S; Oishi M; Goi W; Sakai T
Cell Death Dis; 2016 May; 7(5):e2211. PubMed ID: 27148684
[TBL] [Abstract][Full Text] [Related]
8. Combination of Rapamycin and Resveratrol for Treatment of Bladder Cancer.
Alayev A; Salamon RS; Schwartz NS; Berman AY; Wiener SL; Holz MK
J Cell Physiol; 2017 Feb; 232(2):436-446. PubMed ID: 27225870
[TBL] [Abstract][Full Text] [Related]
9. Resveratrol induces autophagy by directly inhibiting mTOR through ATP competition.
Park D; Jeong H; Lee MN; Koh A; Kwon O; Yang YR; Noh J; Suh PG; Park H; Ryu SH
Sci Rep; 2016 Feb; 6():21772. PubMed ID: 26902888
[TBL] [Abstract][Full Text] [Related]
10. Distinct signaling mechanisms of mTORC1 and mTORC2 in glioblastoma multiforme: a tale of two complexes.
Jhanwar-Uniyal M; Gillick JL; Neil J; Tobias M; Thwing ZE; Murali R
Adv Biol Regul; 2015 Jan; 57():64-74. PubMed ID: 25442674
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of tumor cell growth, proliferation and migration by X-387, a novel active-site inhibitor of mTOR.
Chen SM; Liu JL; Wang X; Liang C; Ding J; Meng LH
Biochem Pharmacol; 2012 May; 83(9):1183-94. PubMed ID: 22305748
[TBL] [Abstract][Full Text] [Related]
12. The anticancer effects of curcumin via targeting the mammalian target of rapamycin complex 1 (mTORC1) signaling pathway.
Tamaddoni A; Mohammadi E; Sedaghat F; Qujeq D; As'Habi A
Pharmacol Res; 2020 Jun; 156():104798. PubMed ID: 32278045
[TBL] [Abstract][Full Text] [Related]
13. The long and winding road to rational treatment of cancer associated with LKB1/AMPK/TSC/mTORC1 signaling.
van Veelen W; Korsse SE; van de Laar L; Peppelenbosch MP
Oncogene; 2011 May; 30(20):2289-303. PubMed ID: 21258412
[TBL] [Abstract][Full Text] [Related]
14. mTOR: more targets of resveratrol?
Widlund AL; Baur JA; Vang O
Expert Rev Mol Med; 2013 Sep; 15():e10. PubMed ID: 24060150
[TBL] [Abstract][Full Text] [Related]
15. Resveratrol inhibits glucose metabolism in human ovarian cancer cells.
Kueck A; Opipari AW; Griffith KA; Tan L; Choi M; Huang J; Wahl H; Liu JR
Gynecol Oncol; 2007 Dec; 107(3):450-7. PubMed ID: 17825886
[TBL] [Abstract][Full Text] [Related]
16. The prosurvival role of autophagy in resveratrol-induced cytotoxicity in GH3 cells.
Zhang X; Xu W; Su J; Chu M; Jin H; Li G; Tan C; Wang X; Wang C
Int J Mol Med; 2014 Apr; 33(4):987-93. PubMed ID: 24534837
[TBL] [Abstract][Full Text] [Related]
17. Molecular targets for cancer therapy in the PI3K/AKT/mTOR pathway.
Polivka J; Janku F
Pharmacol Ther; 2014 May; 142(2):164-75. PubMed ID: 24333502
[TBL] [Abstract][Full Text] [Related]
18. [mTOR inhibitor].
Muro K
Gan To Kagaku Ryoho; 2011 Jan; 38(1):7-11. PubMed ID: 21368454
[TBL] [Abstract][Full Text] [Related]
19. Resveratrol reverses remodeling in hearts with large, old myocardial infarctions through enhanced autophagy-activating AMP kinase pathway.
Kanamori H; Takemura G; Goto K; Tsujimoto A; Ogino A; Takeyama T; Kawaguchi T; Watanabe T; Morishita K; Kawasaki M; Mikami A; Fujiwara T; Fujiwara H; Seishima M; Minatoguchi S
Am J Pathol; 2013 Mar; 182(3):701-13. PubMed ID: 23274061
[TBL] [Abstract][Full Text] [Related]
20. High prevalence of mTOR complex activity can be targeted using Torin2 in papillary thyroid carcinoma.
Ahmed M; Hussain AR; Bavi P; Ahmed SO; Al Sobhi SS; Al-Dayel F; Uddin S; Al-Kuraya KS
Carcinogenesis; 2014 Jul; 35(7):1564-72. PubMed ID: 24583924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
